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1. Experimental section 
 
 1.1. Physical measurements and methods  
 
Melting points were determined on a Mel-Temp capillary melting points apparatus, 
model 1001, and are uncorrected. Elemental (C, H, N, S) analysis of the samples was carried out 
in the Center for Instrumental Analysis, Faculty of Chemistry, Belgrade. IR spectra were 
obtained on a Perkin Elmer Spectrum One FT-IR spectrometer with a KBr disc. 1H and 13C-
NMR spectra were recorded on a Varian Gemini 200 MHz spectrometer. UV–Vis spectra were 
recorded on a double beam UV–Vis spectrophotometer model Cary 300 (Agilent Technologies, 
Santa Clara, USA) with 1.0 cm quartz cells. 
 
 1.2. General procedure for the synthesis of 4a-t  
 
To the aqueous solution of NaOH (21.887 mmol, 3.8 mL of distilled H2O) 
monochloroacetic acid (10.94 mmol, 1033.83mg) and vanillin (9.48 mmol, 1442.38 mg) were 
added, and the reaction mixture was refluxed for 100 minutes. Afterwards, the mixture in the 
flask was cooled to room temperature, 15 mL of distilled H2O was added and the solution was 
acidified with 2M HCl to pH 2, whereby a beige precipitate was formed. The suspension was 
cooled in the refrigerator for 2 h, the precipitate was filtrated, washed with a small amount of 
cold water and dried over anhydrous CaCl2. The crude product was purified by dissolving in hot 
distilled water. After cooling in a refrigerator for 2 h, brown-yellow crystals were formed. The 
compound was filtered off, dried over anhydrous CaCl2 and used for further synthesis. In the 
next step, the compound 2 (2.857 mmol, 600.49 mg) was measured into a 50 mL flask, followed 
by the addition of dry, freshly distilled CH2Cl2 (14.28 mL), SOCl2 (28.57 mmol, 2.07 mL) and 4 
drops of DMF. After 12 h of stirring at room temperature, the solvent was evaporated under 
reduced pressure, and the excess of SOCl2 was removed by azeotropic distillation with toluene. 
Then, a corresponding amine (2.857 mmol), NaHCO3 (5.714 mmol, 479.85 mg) and dry CH2Cl2 
(14.28 mL) were added to the formed acid chloride, without its previous isolation, and the 
reaction mixture was further stirred at room temperature for additional 4.5 h. After completion, 
CH2Cl2 was evaporated under reduced pressure, 28.60 mL of distilled water was added to the 
residue, and the pH was adjusted to 10 by addition of solid Na2CO3. In the case of compounds 
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4b, 4i and 4t this suspension was left overnight at room temperature, vigorously stirred for 20 
minutes the next day and then filtered. In all other cases after pH adjustment, the suspension was 
stirred for 20 minutes and filtered. With exception of 4o, which was obtained with satisfactory 
purity and used for further synthesis without purification, all other 4a-t derivatives were purified 
by dissolving in an appropriate solution of hot aqueous ethanol, and left overnight in the 
refrigerator. Compounds 4a-g, 4j, 4l, 4n, 4r and 4s-t were recrystallized from 50% aqueous 
solution of EtOH, 4i from 55%, 4m and 4p from 60% EtOH, while 4h and 4k were purified by 
recrystallization from 65% EtOH. Derivatives 4a-t were obtained in satisfactory yields ranging 
from 42 to 78%. 
 
1.3. General procedure for the synthesis of quinoline-4-cabroxylic acids 5a-t  
 
A mixture of the corresponding derivatives 4a-t (1 mmol) and freshly distilled pyruvic 
acid (1.5 mmol, 0.132 g) in absolute ethanol (5.8 mL, except 5h) was refluxed for 15 min. In the 
case of compound 5h, 10.4 mL of solvent was added due to poor solubility of the starting 
substrate 4h in absolute ethanol. After cooling the flask, the solution of aniline (1 mmol, 0.093 g) 
in absolute ethanol (1 mL) was added, and the mixture was refluxed for 3 h (10 h for 5h). 
Afterwards, the flask was allowed to stand at 4 ° C overnight, and the formed precipitate of the 
corresponding compounds 5a-t was then filtered and dried over CaCl2. In order to achieve high 
purity of compounds, all derivatives 5a-t (except 5p) were purified by dissolving in a small 
amount of ethanol with mild heating and left in the refrigerator overnight. The compound 5p was 
recrystallized from THF, while derivatives 5a, 5s and 5t after recrystallization from ethanol were 
treated with THF in order to remove ethanol which incorporated into the structure of the 
compounds and then dried at room temperature for 3-5 days after which the amount of ethanol 
was significantly reduced. The final quinoline-4-carboxylic acids were obtained in yields ranging 







1.4. Determination of lipophilicity 
 
 In a volumetric flask 0.5 mg of the corresponding compound was weighed, dissolved in 
100µL of DMF, and diluted to 25 mL with n-octanol (5h, 5i, 5j, 5k, 5l, 5m, 5n, 5p, 5q, 5r, 5s 
and 5t). From this solution 5 mL (5b, 5c, 5d, 5e, 5f и 5g), or 4 mL (5a) was measured and 
diluted with n-octanol to 10mL. Due to the good solubility in water, in the case of compound 5o, 
for stock solution was weighed 1 mg, dissolved in 100µL of DMF, and diluted with n-octanol to 
25 mL in order to obtain a solution of higher concentration so that the concentration after 
treatment would not be too low and deviate from Lambert-Beer's law. The absorbance of tested 
compounds in these n-octanol solutions was measured by UV-Vis spectrophotometry. 
Afterwards, 4 mL of each n-octanol solution and 8 mL of phosphate buffer was shaken on 
mechanical shaker for 30 minutes. After phase separation, n-octanol layer was dried over 
anhydrous sodium sulphate and absorbance of this layer was measured. The concentrations of 
each compound before and after treatment on mechanical shaker are shown in Table 1. LogD7.4 
value was determined using equation: logD7.4 = log(y/x−y) where x represents concentration of 
compound in n-octanol phase before shaking and y represents concentration of compound in n-
octanol phase after the treatment on mechanical shaker. For each compound, five independent 
















Table 1. The concentrations of tested compounds before and after the treatment.  
 
compd. C1(M) λ(nm) C2(M) 
5a 1.8672×10-5 348 1.5660×10-5 
5b 2.2601×10-5 346 1.9768×10-5 
5c 2.2601×10-5 348 2.1973×10-5 
5d 2.1716×10-5 348 2.0319×10-5 
5e 2.1121×10-5 346 1.8627×10-5 
5f 2.1957×10-5 347 2.1412×10-5 
5g 2.1957×10-5 348 2.0296×10-5 
5h 4.2383×10-5 348 4.1333×10-5 
5i 4.2383×10-5 344 4.2184×10-5 
5j 4.2383×10-5 348 4.1146×10-5 
5k 3.9569×10-5 352 3.7700×10-5 
5l 3.9569×10-5 348 3.7885×10-5 
5m 3.8207×10-5 348 3.7348×10-5 
5n 4.5202×10-5 348 3.3434×10-5 
5o 8.6679×10-5 350 1.1823×10-5 
5p 4.4400×10-5 348 1.4208×10-5 
5q 4.3714×10-5 348 2.1677×10-5 
5r 4.5819×10-5 349 4.1726×10-5 
5s 4.6032×10-5 347 3.9603×10-5 
5t 3.9637×10-5 339 3.6328×10-5 
C1 - concentration of tested compound in n-octanol phase before distribution (mol L
-1); 
λ - wavelength at the absorption maximum (nm); 




1.5. Characterisation data for 4a-t and 5a-5t derivatives  
 
1.5.1. 2-(4-Formyl-2-methoxyphenoxy)-N-phenylacetamide × 0.5H2O (4a): Beige powder; yield: 
0.619g (76%); mp 148-149 ºC; IR (KBr, cm-1): 3437, 1680, 1601, 1561, 1278, 1135, 751; 1H 
NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.86 (s, 2H, CH2), 7.04-7.14 (m, 2H, Ar-H), 
7.29-7.36 (m, 2H, Ar-H,), 7.45 (d, 1H, Ar-H, J = 1.8 Hz), 7.52-7.63 (m, 3H, Ar-H), 9.85 (s, 1H, 
CHO), 10.20 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): 55.82, 67.88, 110.30, 112.95, 119.54 
(2C), 123.80, 125.67, 128.90 (2C), 130.42, 138.45, 149.42, 152.88, 165.88, 191.39; Anal. Calcd. 





1.5.2 2-(4-Formyl-2-methoxyphenoxy)-N-(o-tolyl)acetamide (4b): Light beige powder; yield: 
0.632g (74%); mp 133-134 ºC; IR (KBr, cm-1): 3438, 3396, 1685, 1596, 1507, 1278, 1135, 762; 
1H NMR (200 MHz, DMSO-d6): 2.22 (s, 3H, CH3), 3.89 (s, 3H, OCH3), 4.90 (s, 2H, CH2), 7.05-
7.26 (m, 4H, Ar-H), 7.46 (d, 1H, Ar-H, J = 1.8 Hz), 7.55-7.60 (m, 2H, Ar-H), 9.44 (s, 1H, NH), 
9.87 (s, 1H, CHO); 13C NMR (50 MHz, DMSO-d6): 17.66, 55.86, 67.75, 110.30, 113.04, 124.06, 
125.34, 125.60, 126.20, 130.44, 130.51, 130.92, 135.57, 149.43, 152.57, 165.87, 191.49; Anal. 
Calcd. For C17H17NO4 (299.32 g/mol): C, 68.21; H, 5.72; N, 4.68; Found: C, 66.83; H, 5.46; N, 
4.61. 
 
1.5.3 2-(4-Formyl-2-methoxyphenoxy)-N-(m-tolyl)acetamide (4c): Beige powder; yield: 0.538g 
(63%); mp 108-109 ºC; IR (KBr, cm-1): 3436, 3380, 1682, 1507, 1276, 1134, 1031, 733; 1H 
NMR (200 MHz, DMSO-d6): 2.27 (s, 3H, CH3), 3.88 (s, 3H, OCH3), 4.85 (s, 2H, CH2), 6.89 (d, 
1H, Ar-H, J = 7.4 Hz), 7.09-7.24 (m, 2H, Ar-H), 7.37-7.45 (m, 3H, Ar-H), 7.54 (dd, 1H, Ar-H, J 
= 8.3 Hz and J  =1.9 Hz), 9.85 (s, 1H, CHO), 10.12 (s, 1H, NH); 
13C NMR (50 MHz, DMSO-d6): 
21.33, 55.82, 67.90, 110.34, 112.97, 116.72, 120.05, 124.48, 125.64, 128.71, 130.42, 138.10, 
138.36, 149.42, 152.89, 165.79, 191.34; Anal. Calcd. For C17H17NO4 (299.32 g/mol): C, 68.21; 
H, 5.72; N, 4.68; Found: C, 67.89; H, 5.54; N, 4.64. 
 
1.5.4. 2-(4-Formyl-2-methoxyphenoxy)-N-(p-tolyl)acetamide (4d): Light brown powder; yield: 
0.572g (67%); mp 129-130 ºC; IR (KBr, cm-1): 3437, 3241, 1667, 1509, 1282, 1141, 1027, 813; 
1H NMR (200 MHz, DMSO-d6): 2.25 (s, 3H, CH3), 3.87 (s, 3H, OCH3), 4.83 (s, 2H, CH2), 7.12 
(m, 3H, Ar-H), 7.44-7.56 (m, 4H, Ar-H), 9.84 (s, 1H, CHO), 10.10 (s, 1H, NH); 13C NMR (50 
MHz, DMSO-d6): 20.45, 55.78, 67.91, 110.31, 112.97, 119.51 (2C), 125.58, 129.20 (2C), 
130.38, 132.71, 135.88, 149.39, 152.86, 165.56, 191.30; Anal. Calcd. For C17H17NO4 (299.32 
g/mol): C, 68.22; H, 5.72; N, 4.68; Found: C, 67.81; H, 5.53; N, 4.68. 
  
1.5.5. N-(2-Fluorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0.5H2O  (4e): Beige 
powder; yield: 0.528g (61%); mp 130-131 ºC; IR (KBr, cm-1): 3381, 1701, 1657, 1545, 1278, 
1134, 762; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.94 (s, 2H, CH2), 7.13-7.85 
(m, 4H, Ar-H), 7.45 (d, 1H, Ar-H, J = 1.8 Hz), 7.55 (dd, 1H, J = 8.2 Hz and J  = 1.8 Hz), 7.90-
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7.98 (m, 1H, Ar-H), 9.86 (s, 1H, CHO), 9.91 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): 
55.86, 67.68, 110.36, 113.42, 115.58 (JCF = 19.15 Hz), 123.76 (C-F), 124.55 (JCF = 3.55 Hz), 
125.40 (C-F), 125.57 (C-F), 125.76, 130.53, 149.42, 152.63, 153.53 (JCF = 243.40 Hz), 166.32, 
191.11; Anal. Calcd. For C16H14FNO4 × 0.5H2O (312.28 g/mol): C, 61.54; H, 4.84; N, 4.49; 
Found: C, 61.70; H, 4.75; N, 4.53. 
 
1.5.6. N-(3-Fluorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0,5H2O (4f): Light 
brown powder; yield: 0.641g (74%); mp 135-136 ºC; IR (KBr, cm-1): 3382, 3154, 1682, 1615, 
1508, 1268, 1134, 853, 735; 1H NMR (200 MHz, DMSO-d6): 3.89 (s, 3H, OCH3), 4.89 (s, 2H, 
CH2), 6.87-6.98 (m, 1H, Ar-H), 7.13 (d, 1H, Ar-H, J = 8.4 Hz), 7.35-7.40 (m, 2H, Ar-H), 7.44-
7.46 (m, 1H, Ar-H), 7.53-7.65 (m, 2H, Ar-H), 9.86 (s, 1H, CHO), 10.46 (s, 1H, NH); 13C NMR 
(50 MHz, DMSO-d6): 55.81, 67.83, 106.37 (JCF = 26.05 Hz), 110.03 (C-F), 110.40, 113.05, 
115.29 (JCF = 2.20 Hz), 125.57, 130.48, 130.51 (JCF = 9.35 Hz), 140.14 (JCF = 11.10 Hz), 149.43, 
152.79, 162.16 (JCF = 239.95 Hz), 166.29, 191.33; Anal. Calcd. For C16H14FNO4 × 0.5H2O 
(312.28 g/mol): C, 61.54; H, 4.84; N, 4.49; Found: C, 61.73; H, 4.76; N, 4.54. 
 
1.5.7. N-(4-Fluorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0.5H2O (4g): Light beige 
powder; yield: 0.606g (70%); mp 139-140 ºC; IR (KBr, cm-1): 3346, 1686, 1508, 1285, 1031, 
819; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.85 (s, 2H, CH2), 7.10-7.21 (m, 3H, 
Ar-H), 7.44 (d, 1H, Ar-H, J = 1.8 Hz), 7.54 (dd, 1H, Ar-H, J = 8.3 Hz and J = 1.9 Hz), 7.60-7.67 
(m, 2H, Ar-H), 9.85 (s, 1H, CHO), 10.28 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): 55.78, 
67.82, 110.29, 112.97, 115.43 (JCF = 22.15 Hz), 121.35 (JCF = 7.75 Hz), 125.61 (2C), 130.41, 
134.81 (JCF = 2.55 Hz), 149.40, 152.61, 152.83, 158.27 (JCF = 238.50 Hz), 165.81, 191.35; Anal. 
Calcd. For C16H14FNO4 × 0.5H2O (312.28 g/mol): C, 61.54; H, 4.84; N, 4.49; Found: C, 61.50; 
H, 4.74; N, 4.50. 
 
1.5.8. N-(2-Chlorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0.5H2O (4h): Light pink 
powder; yield: 0.638g (70%); mp 164-165 ºC; IR (KBr, cm-1): 3361, 1698, 1536, 1434, 1265, 
1135, 1032, 733; 1H NMR (200 MHz, DMSO-d6): 3.90 (s, 3H, CH3), 4.94 (s, 2H, CH2), 7.17-
7.25 (m, 2H, Ar-H), 7.33-7.42 (m, 1H, Ar-H), 7.47 (d, 1H, Ar-H, J = 1.8 Hz), 7.52-7.60 (m, 2H, 
Ar-H), 8.02 (dd, 1H, Ar-H, J = 8.2 Hz and J = 1.6 Hz), 9.64 (s, 1H, NH), 9.88 (s, 1H, CHO); 13C 
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NMR (50 MHz, DMSO-d6): 55.90, 67.66, 110.28, 113.24, 123.87, 124.83, 125.57, 126.15, 
127.81, 129.54, 130.69, 134.08, 149.41, 152.12, 166.19, 191.41; Anal. Calcd. For C16H14ClNO4 
× 0.5H2O (328.74 g/mol): C, 58.46; H, 4.60; N, 4.26; Found: C, 58.79; H, 4.46; N, 4.31. 
 
1.5.9. N-(3-Chlorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0.5H2O (4i): Yellow 
powder; yield: 0.710g (78%); mp 113-114 ºC; IR (KBr, cm-1): 3366, 1679, 1596, 1508, 1279, 
1139, 1031, 676; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, CH3), 4.89 (s, 2H, CH2), 7.11-
7.18 (m, 2H, Ar-H), 7.36 (m, 1H, Ar-H), 7.45-7.57 (m, 3H, Ar-H), 7.83 (t, 1H, Ar-H, J = 2.0 Hz), 
9.86 (s, 1H, CHO), 10.43 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): 55.79, 67.78, 110.37, 
113.04, 117.91, 119.02, 123.44, 125.54, 130.46, 130.51, 133.16, 139.84, 149.40, 152.76, 166.30, 
191.29; Anal. Calcd. For C16H14ClNO4 × 0.5H2O (328.74 g/mol): C, 58.46; H, 4.60; N, 4.26; 
Found: C, 58.79; H, 4.53; N, 4.37. 
 
1.5.10. N-(4-Chlorophenyl)-2-(4-formyl-2-methoxyphenoxy)acetamide × 0.5H2O (4j): Light 
beige powder; yield: 0.628g (69%); mp 135-136 ºC; IR (KBr, cm-1): 3389, 1683, 1589, 1507, 
1277, 1137, 1028, 803; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, CH3), 4.87 (s, 2H, CH2), 
7.12 (d, 1H, Ar-H, J = 8.4 Hz), 7.36-7.46 (m, 3H, Ar-H), 7.54 (dd, 1H, Ar-H, J = 8.2 Hz and J  =  
1.8 Hz), 7.61-7.69 (m, 2H, Ar-H), 9.85 (s, 1H, CHO), 10.36 (s, 1H, NH); 13C NMR (50 MHz, 
DMSO-d6): 55.78, 67.82, 110.31, 112.98, 121.07 (2C), 125.59, 127.35, 128.76 (2C), 130.42, 
137.38, 149.39, 152.79, 166.05, 191.33; Anal. Calcd. For C16H14ClNO4 × 0.5H2O (328.74 
g/mol): C, 58.46; H, 4.60; N, 4.26; Found: C, 58.29; H, 4.44; N, 4.30. 
 
1.5.11. 2-(4-Formyl-2-methoxyphenoxy)-N-(2-(trifluoromethyl)phenyl)acetamide × 0.5H2O (4k): 
White powder; yield: 0.735g (73%); mp 155-156 ºC; IR (KBr, cm-1): 3392, 3252, 1676, 1589, 
1318, 1117, 770;  1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.91 (s, 2H, CH2), 7.17 
(d, 1H, Ar-H, J = 8.2 Hz), 7.41-7.49 (m, 2H, Ar-H), 7.57 (dd, 1H, Ar-H, J = 8.2 Hz and J = 1.8 
Hz), 7.67-7.84 (m, 3H, Ar-H), 9.63 (s, 1H, NH), 9.87 (s, 1H, CHO); 13C NMR (50 MHz, DMSO-
d6): 55.83, 67.49, 110.25, 113.12, 123.75 (JCF = 271.00 Hz), 122.69 (JCF = 28.95 Hz), 125.52, 
126.36 (C-F), 126.46 (C-F), 127.59 (C-F), 133.31 (C-F), 130.70, 134.56 (C-F), 149.42, 152.15, 
166.77, 191.43; Anal. Calcd. For C17H14F3NO4 × 0.5H2O (362.29 g/mol): C, 56.36; H, 4.17; N, 




1.5.12. 2-(4-Formyl-2-methoxyphenoxy)-N-(3-(trifluoromethyl)phenyl)acetamide × 0.5H2O (4l): 
Light yellow powder; yield: 0.766g (76%); mp 120-121 ºC; IR (KBr, cm-1): 3387, 1690, 1590, 
1545, 1338, 1271, 1117, 695; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.91 (s, 2H, 
CH2), 7.13 (d, 1H, Ar-H, J = 8.2 Hz), 7.41-7.45 (m, 2H, Ar-H), 7.51-7.61 (m, 2H, Ar-H), 7.81 (d, 
1H, Ar-H, J = 8 Hz), 8.11 (s, 1H, Ar-H), 9.85 (s, 1H, CHO), 10.60 (s, 1H, NH); 13C NMR (50 
MHz, DMSO-d6): 55.80, 67.74, 110.37, 113.05, 115.61 (JCF = 4.05 Hz), 120.05 (JCF = 3.55 Hz), 
123.08 (C-F), 124.09 (JCF = 270.15 Hz), 125.56, 129.57 (JCF = 31.45 Hz), 130.08, 130.47 (C-F), 
139.21 (C-F), 149.41, 152.77, 166.57, 191.32; Anal. Calcd. For C17H14F3NO4 × 0.5H2O (362.29 
g/mol): C, 56.36; H, 4.17; N, 3.87; Found: C, 56.40; H, 4.10; N, 3.93. 
 
1.5.13. 2-(4-Formyl-2-methoxyphenoxy)-N-(4-(trifluoromethyl)phenyl)acetamide (4m): White 
powder; yield: 0.736g (73%); mp 154-155 ºC; IR (KBr, cm-1): 3257, 1675, 1542, 1325, 1140, 
1067, 841; 1H NMR (200 MHz, DMSO-d6): 3.88 (s, 3H, OCH3), 4.91 (s, 2H, CH2), 7.13 (d, 1H, 
Ar-H, J = 8.2 Hz), 7.45 (d, 1H, Ar-H, J = 1.8 Hz), 7.54 (dd, 1H, Ar-H, J = 8.3 Hz and J =1.9 
Hz), 7.69 (d, 2H, Ar-H, J = 8.8 Hz), 7.83 (d, 2H, Ar-H, J = 8.6 Hz), 9.85 (s, 1H, CHO), 10.60 (s, 
1H, NH); 13C NMR (50 MHz, DMSO-d6): 55.80, 67.77, 110.37, 113.02, 119.42 (2C, C-F), 
123.15 (JCF = 31.70 Hz), 124.36 (JCF = 269.60 Hz), 125.56 (2C), 126.16 (JCF = 3.47 Hz), 130.46, 
142.01 (C-F), 149.40, 152.76, 166.57, 191.33; Anal. Calcd. For C17H14F3NO4 (353.29 g/mol): C, 
57.79; H, 3.99; N, 3.96; Found: C, 38.50; H, 2.67; N, 2.67. 
 
1.5.14. N-Benzyl-2-(4-formyl-2-methoxyphenoxy)acetamide (4n): Beige powder; yield: 0.512g 
(60%); mp 105-106 ºC; IR (KBr, cm-1): 3423, 1678, 1590, 1514, 1274, 1123, 1028, 782; 1H 
NMR (200 MHz, DMSO-d6): 3.85 (s, 3H, CH3), 4.35 (d, 2H, NHCH2, J = 6.0 Hz), 4.72 (s, 2H, 
CH2), 7.09 (d, 1H, Ar-H, J = 8.4 Hz), 7.19-7.37 (m, 5H, Ar-H), 7.44 (d, 1H, Ar-H, J = 1.8 Hz), 
7.53 (dd, 1H, Ar-H, J = 8.2 Hz and J = 1.8 Hz), 8.56 (t, 1H, NH, J = 6.0 Hz), 9.86 (s, 1H, CHO); 
13C NMR (50 MHz, DMSO-d6): 42.11, 55.76, 67.87, 110.23, 113.15, 125.55, 126.91, 127.34 
(2C), 128.32 (2C), 130.47, 139.13, 149.47, 152.74, 167.17, 191.38; Anal. Calcd. For C17H17NO4 




1.5.15. 2-(4-Formyl-2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)acetamide (4o): White powder; 
yield: 0.583g (68%); mp 75-76 ºC; IR (KBr, cm-1): 3488, 3387, 3200, 1656, 1508, 1265, 1138, 
732; 1H NMR (200 MHz, DMSO-d6): 3.85 (s, 3H, CH3), 4.35 (d, 2H, NHCH2, J = 6.0 Hz), 4.72 
(s, 2H, CH2), 7.08 (d, 1H, Ar-H, J = 8.2 Hz), 7.31-7.38 (m, 1H, Py-H), 7.44 (d, 1H, Ar-H, J = 1.6 
Hz), 7.52 (dd, 1H, Ar-H, J  = 8.2 Hz and J =1.8 Hz), 7.64-7.68 (m, 1H, Py-H), 8.44-8.50 (m, 2H, 
Py-H), 8.68 (t, 1H, NH, J = 6.0 Hz), 9.86 (s, 1H, CHO); 13C NMR (50 MHz, DMSO-d6): 39.91, 
55.81, 67.86, 110.25, 113.14, 123.54, 125.63, 130.52, 134.75, 135.24, 148.23, 148.89, 149.50, 
152.74, 167.52, 191.49; Anal. Calcd. For C16H16N2O4 (300.31 g/mol): C, 63.99; H, 5.37; N, 9.33; 
Found: C, 54.48; H, 5.53; N, 7.87. 
 
1.5.16. 2-(4-Formyl-2-methoxyphenoxy)-N-(furan-2-ylmethyl)acetamide (4p): Light brown 
powder; yield: 0.347g (42%); mp 80-81 ºC; IR (KBr, cm-1): 3272, 1682, 1654, 1508, 1263, 1136, 
1030, 735; 1H NMR (200 MHz, DMSO-d6): 3.86 (s, 3H, CH3), 4.34 (d, 2H, NHCH2, J = 5.8 Hz), 
4.68 (s, 2H, CH2), 6.25 (dd, 1H, Fur-H, J = 3.2 Hz and J = 0.8 Hz), 6.40 (m, 1H, Fur-H), 7.07 (d, 
1H, Ar-H, J = 8.4), 7.43 (d, 1H, Ar-H, J = 1.8 Hz), 7.53 (dd, 1H, Ar-H, J  = 8.2 Hz and J  = 1.8 
Hz), 7.59 (m, 1H, Fur-H), 8.52 (t, 1H, NH, J = 5.8 Hz), 9.85 (s, 1H, CHO); 13C NMR (50 MHz, 
DMSO-d6): 35.51, 55.77, 67.75, 107.03, 110.29, 110.52, 113.16, 125.50, 130.47, 142.16, 149.45, 
151.90, 152.73, 167.04, 191.34; Anal. Calcd. For C15H15NO5 (289.28 g/mol): C, 62.28; H, 5.23; 
N, 4.84; Found: C, 62.19; H, 5.25; N, 4.79. 
 
1.5.17. 2-(4-Formyl-2-methoxyphenoxy)-N-(thiophen-2-ylmethyl)acetamide × 0.5H2O (4q): 
White powder; yield: 0.636g (73%); mp 123-124 ºC; IR (KBr, cm-1): 3274, 1660, 1506, 1257, 
1136, 1026, 704; 1H NMR (200 MHz, DMSO-d6): 3.85 (s, 3H, CH3), 4.50 (d, 2H, NHCH2, J = 
6.0 Hz), 4.69 (s, 2H, CH2), 6.93-6.99 (m, 2H, Thio-H), 7.06 (d, 1H, Ar-H, J = 8.2 Hz), 7.39-7.44 
(m, 2H, Ar-H, Thio-H), 7.52 (dd, 1H, Ar-H, J  = 8.2 Hz and J  = 1.8 Hz), 8.68 (t, 1H, NH, J = 6.0 
Hz), 9.85 (s, 1H, CHO); 13C NMR (50 MHz, DMSO-d6): 37.22, 55.78, 67.72, 110.20, 113.10, 
125.24, 125.60, 125.73, 126.74, 130.46, 141.99, 149.45, 152.72, 167.06, 191.43; Anal. Calcd. 
For C15H15NO4S × 0.5H2O (314.35 g/mol): C, 57.31; H, 5.13; N, 4.46; S, 10.20; Found: C, 




1.5.18. 2-(4-Formyl-2-methoxyphenoxy)-N-hexylacetamide (4r): White powder; yield: 0.485g 
(58%); mp 76-77 ºC; IR (KBr, cm-1): 3291, 2934, 1653, 1549, 1284, 1140, 1027, 737; 1H NMR 
(200 MHz, DMSO-d6): 0.85 (t, 3H, CH3, J = 6.5 Hz), 1.23-1.44 (m, 8H, CH2), 3.12 (q, 2H, -NH-
CH2-CH2-, J = 6.4 Hz), 3.86 (s, 3H, OCH3), 4.61 (s, 2H, -OCH2-CO-), 7.05 (d, 1H, Ar-H, J = 8.2 
Hz), 7.43 (d, 1H, Ar-H, J = 1.8 Hz), 7.53 (dd, 1H, Ar-H, J = 8.3 Hz and J = 1.9 Hz), 7.99 (t, 1H, 
NH, J = 5.5 Hz), 9.85 (s, 1H, CHO); 13C NMR (50 MHz, DMSO-d6): 13.99, 22.16, 26.10, 29.07, 
31.06, 38.46, 55.76, 67.91, 110.27, 113.08, 125.47, 130.42, 149.43, 152.75, 166.79, 191.28; 
Anal. Calcd. For C16H23NO4 (293.36 g/mol): C, 65.51; H, 7.90; N, 4.77; Found: C, 65.07; H, 
7.63; N, 4.73. 
 
1.5.19. N-Cyclohexyl-2-(4-formyl-2-methoxyphenoxy)acetamide (4s): White powder; yield: 
0.482g (58%); mp 137-138 ºC; IR (KBr, cm-1): 3418, 2933, 1683, 1508, 1265, 1148, 1034, 810; 
1H NMR (200 MHz, DMSO-d6): 1.02-1.75 (m, 10H, cyclohexyl), 3.57 (m, 1H, cyclohexyl), 3.86 
(s, 3H, CH3), 4.60 (s, 2H, -OCH2-), 7.05 (d, 1H, Ar-H, J = 8.2 Hz), 7.43 (d, 1H, Ar-H, J = 1.8 
Hz), 7.53 (dd, 1H, Ar-H, J = 8.3 Hz and J = 1.9 Hz), 7.88 (d, 1H, NH, J = 8 Hz), 9.85 (s, 1H, 
CHO); 13C NMR (50 MHz, DMSO-d6): 24.53 (2C), 25.25, 32.31 (2C), 47.50, 55.77, 67.89, 
110.27, 113.16, 125.50, 130.37, 149.40, 152.83, 165.89, 191.28; Anal. Calcd. For C16H21NO4 
(291.34 g/mol): C, 65.96; H, 7.27; N, 4.81; Found: C, 62.64; H, 6.76; N, 4.43. 
 
1.5.20. N-((1s,3s)-Adamantan-1-yl)-2-(4-formyl-2-methoxyphenoxy)acetamide (4t): Light yellow 
powder; yield: 0.470g (48%); mp 137-138 ºC; IR (KBr, cm-1): 3382, 2912, 1683, 1590, 1276, 
1164, 1039, 810; 1H NMR (200 MHz, DMSO-d6): 1.62 (s, 6H, Ad), 1.95-2.02 (m, 9H, Ad), 3.86 
(s, 3H, CH3), 4.55 (s, 2H, CH2), 7.07 (d, 1H, Ar-H, J = 8.2 Hz), 7.41-7.43 (m, 2H, Ar-H, NH), 
7.54 (dd, 1H, Ar-H, J = 8.2 Hz and J = 1.8 Hz), 9.85 (s, 1H, CHO); 
13C NMR (50 MHz, DMSO-
d6): 28.94 (3C), 36.04 (3C), 41.06 (3C), 51.10, 55.82, 67.86, 110.25, 113.13, 125.57, 130.34, 
149.35, 152.76, 165.88, 191.29; Anal. Calcd. For C20H25NO4 (343.42 g/mol): C, 69.95; H, 7.34; 
N, 4.08; Found: C, 67.56; H, 6.81; N, 3.88. 
  
1.5.21. 2-(3-Methoxy-4-(2-oxo-2-(phenylamino)ethoxy)phenyl)quinoline-4-carboxylic acid (5a): 
Light yellow powder; yield: 0.146g (34%); mp 205-206 ºC; IR (KBr, cm-1): 3299, 2959, 1707, 
1657, 1596, 1424, 1211, 1034, 866, 761; 1H NMR (200 MHz, DMSO-d6): 3.98 (s, 3H, CH3), 
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4.81 (s, 2H, CH2), 7.05-7.15 (m, 2H, Ar-H), 7.30-7.38 (m, 2H, Ar-H), 7.62-7.72 (m, 3H, Ar-H), 
7.80-7.90 (m, 2H, Ar-H), 7.96 (d, 1H, J = 2 Hz), 8.17 (dd , 1H, Ar-H, J = 8.4 Hz and J = 0.6 Hz), 
8.45 (s, 1H, Ar-H), 8.60 (dd, 1H, Ar-H, J = 8.4 Hz and J = 1 Hz), 10.17 (s, 1H, NH); 
13C NMR 
(50 MHz, DMSO-d6): 56.05, 68.52, 111.08, 114.32, 118.89, 119.64 (2C), 120.34, 123.24, 
123.76, 125.41, 127.44, 128.84 (2C), 129.69, 130.15, 131.90, 137.71, 138.45, 148.36, 149.41, 
149.60, 155.45, 166.40, 167.72; Anal. Calcd. For C25H20N2O5 (428.44 g/mol): C, 70.08; H, 4.71; 
N, 6.54; Found: C, 70.39; H, 4.72; N, 6.56. 
 
1.5.22. 2-(3-Methoxy-4-(2-oxo-2-(o-tolylamino)ethoxy)phenyl)quinoline-4-carboxylic acid (5b): 
Beige powder; yield: 0.126g (28%); mp 246-247 ºC; IR (KBr, cm-1): 3446, 3372, 2921, 1719, 
1644, 1598, 1519, 1245, 756; 1H NMR (200 MHz, DMSO-d6): 2.24 (s, 3H, CH3), 3.98 (s, 3H, 
OCH3), 4.84 (s, 2H, CH2), 7.05-7.25 (m, 4H, Ar-H), 7.57-7.71 (m, 2H, Ar-H), 7.79-7.91 (m, 2H, 
Ar-H), 7.97 (d, 1H, Ar-H, J = 1.8 Hz), 8.15 (d, 1H, Ar-H, J = 8.0 Hz), 8.46 (s, 1H, Ar-H), 8.59 
(d, 1H, Ar-H, J = 8.2 Hz), 9.42 (s, 1H, NH), 14.03 (bs, 1H, COOH); 13C NMR (50 MHz, 
DMSO-d6): 17.57, 56.03, 68.22, 110.96, 114.16, 118.83, 120.27, 123.21, 123.91, 125.24, 125.37, 
126.18, 127.41, 129.65, 130.12, 130.39, 130.75, 131.91, 135.60, 137.71, 148.32, 149.09, 149.51, 
155.38, 166.31, 167.68; Anal. Calcd. For C26H22N2O5 (442.46 g/mol): C, 70.58; H, 5.01; N, 6.33; 
Found: C, 70.42; H, 5.01; N, 6.35. 
 
1.5.23. 2-(3-Methoxy-4-(2-oxo-2-(m-tolylamino)ethoxy)phenyl)quinoline-4-carboxylic acid (5c): 
Beige yellow powder; yield: 0.133g (30%); mp 225-226 ºC; IR (KBr, cm-1): 3384, 2921, 2599, 
1717, 1643, 1561, 1520, 1421, 1237, 776; 1H NMR (200 MHz, DMSO-d6): 2.28 (s, 3H, CH3), 
3.98 (s, 3H, OCH3), 4.80 (s, 2H, CH2), 6.90 (d, 1H, Ar-H, J = 7.4 Hz), 7.11 (d, 1H, Ar-H, J = 8.6 
Hz), 7.21 (t, 1H, Ar-H, J = 7.8 Hz), 7.40-7.48 (m, 2H, Ar-H), 7.62-7.71 (m, 1H, Ar-H), 7.78-7.88 
(m, 2H, Ar-H), 7.96 (d, 1H, Ar-H, J = 2 Hz), 8.14 (dd, 1H, Ar-H, J = 8.2 Hz and J = 0.6 Hz), 
8.45 (s, 1H, Ar-H), 8.59 (dd, 1H, Ar-H, J = 8.5 Hz and J = 1.0 Hz), 10.08 (s, 1H, NH), 13.99 (bs, 
1H, COOH); 13C NMR (50 MHz, DMSO-d6): 21.25, 55.99, 68.45, 111.02, 114.23, 116.74, 
118.82, 120.08, 120.27, 123.18, 124.39, 125.34, 127.37, 128.61, 129.62, 130.07, 131.81, 137.63, 
138.00, 138.29, 148.29, 149.35, 149.53, 155.38, 166.25, 167.65; Anal. Calcd. For C26H22N2O5 




1.5.24. 2-(3-Methoxy-4-(2-oxo-2-(p-tolylamino)ethoxy)phenyl)quinoline-4-carboxylic acid ×  
1H2O  (5d): Beige powder; yield: 0.150g (34%); mp 224-225 ºC; IR (KBr, cm
-1): 3372, 2921, 
2511, 1707, 1640, 1549, 1349, 1269, 1127, 1036, 808; 1H NMR (200 MHz, DMSO-d6): 2.26 (s, 
3H, CH3), 3.97 (s, 3H, OCH3), 4.78 (s, 2H, CH2), 7.13 (m, 3H, Ar-H), 7.52 (d, 2H, Ar-H, J = 8.2 
Hz), 7.62-7.71 (m, 1H, Ar-H), 7.78-7.88 (m, 2H, Ar-H), 7.96 (d, 1H, Ar-H, J = 1.8 Hz), 8.14 (d, 
1H, Ar-H, J = 8.2 Hz), 8.44 (s, 1H, Ar-H), 8.59 (d, 1H, Ar-H, J = 8.2 Hz), 10.06 (s, 1H, NH), 
14.00 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 20.53, 55.97, 68.49, 110.99, 114.27, 
118.80, 119.58 (2C), 120.26, 123.18, 125.34, 127.35, 129.14 (2C), 129.61, 130.06, 131.82, 
132.66, 135.84, 137.67, 148.29, 149.35, 149.53, 155.37, 166.07, 167.65; Anal. Calcd. For 




acid × 1.5H2O (5e): Beige powder; yield: 0.192g (43%); mp 248-249 ºC; IR (KBr, cm
-1): 3372, 
2922, 1714, 1622, 1556, 1519, 1266, 1207, 1036, 749; 1H NMR (200 MHz, DMSO-d6): 3.98 (s, 
3H, CH3), 4.89 (s, 2H, CH2), 7.13-7.36 (m, 4H, Ar-H), 7.63-7.71 (m, 1H, Ar-H), 7.79-7.90 (m, 
2H, Ar-H), 7.93-8.02 (m, 2H, Ar-H), 8.14 (d, 1H, Ar-H, J = 7.8 Hz), 8.46 (s, 1H, Ar-H), 8.60 (d, 
1H, Ar-H, J = 7.8 Hz), 9.86 (s, 1H, NH), 13.74 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-
d6): 56.05, 68.33, 111.05, 114.48, 115.51 ( JCF = 19.15 Hz), 118.88, 120.30, 123.26, 123.69 (C-
F), 124.51 (JCF = 3.45 Hz), 125.41 (JCF = 1.2 Hz), 125.52 (C-F), 125.66, 127.38, 129.65, 130.07, 
132.09, 137.69, 148.35, 149.14, 149.58, 153.51 (JCF = 243.15 Hz), 155.38, 166.78, 167.70; Anal. 
Calcd. For C25H19FN2O5 × 1.5H2O (473.46 g/mol): C, 63.42; H, 4.68; N, 5.92; Found: C, 63.21; 
H, 4.57; N, 5.91. 
 
1.5.26. 2-(4-(2-((3-Fluorophenyl)amino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic 
acid × 0.5H2O (5f): Light orange powder; yield: 0.134g (30%); mp 237-238 ºC; IR (KBr, cm
-1): 
3437, 3394, 1699, 1605, 1548, 1425, 1262, 773, 680; 1H NMR (200 MHz, DMSO-d6): 3.98 (s, 
3H, CH3), 4.83 (s, 2H, CH2), 6.88-6.98 (m, 1H, Ar-H), 7.13 (d, 1H, Ar-H, J = 8.4 Hz), 7.36-7.41 
(m, 2H, Ar-H), 7.60-7.72 (m, 2H, Ar-H), 7.80-7.89 (m, 2H, Ar-H), 7.97 (d, 1H, Ar-H, J = 2 Hz), 
8.15 (dd, 1H, Ar-H, J = 8.2 Hz and J = 0.6 Hz), 8.45 (s, 1H, Ar-H), 8.60 (dd, 1H, Ar-H, J = 8.4 
Hz and J = 1 Hz), 10.40 (s, 1H, NH), 13.99 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 
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56.00, 68.47, 106.46 (JCF = 26.05 Hz), 110.21 (JCF = 20.95 Hz), 111.09, 114.37, 115.37 (JCF = 
1.75 Hz), 118.86, 120.29, 123.26, 125.41, 127.37, 129.65, 130.08, 130.44 (JCF = 9.4 Hz), 131.99, 
137.77, 140.14 (JCF = 10.95 Hz), 148.34, 149.29, 149.59, 155.40, 162.15 (JCF = 239.9 Hz), 
166.82, 167.72; Anal. Calcd. For C25H19FN2O5 × 0.5H2O (455.44 g/mol): C, 65.93; H, 4.43; N, 
6.15; Found: C, 65.71; H, 4.35; N, 6.15. 
 
1.5.27. 2-(4-(2-((4-Fluorophenyl)amino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic 
acid × 0.5H2O (5g): Light yellow powder; yield: 0.174g (39%); mp 212-213 ºC; IR (KBr, cm
-1): 
3065, 2600, 1705, 1663, 1548, 1508, 1424, 1209, 813; 1H NMR (200 MHz, DMSO-d6): 3.99 (s, 
3H, CH3), 4.81 (s, 2H, CH2), 7.12-7.25 (m, 3H, Ar-H), 7.65-7.72 (m, 3H, Ar-H), 7.80-7.90 (m, 
2H, Ar-H), 7.98 (d, 1H, Ar-H, J = 1.8 Hz), 8.15 (d, 1H, Ar-H, J = 8 Hz), 8.46 (s, 1H, Ar-H), 8.61 
(d, 1H, Ar-H, J = 7.8 Hz), 10.24 (s, 1H, NH), 14.00 (bs, 1H, COOH); 13C NMR (50 MHz, 
DMSO-d6): 55.98, 68.51, 111.07, 114.39, 115.31 (JCF = 22.15 Hz), 118.81, 120.26, 121.46 (JCF 
= 7.8 Hz), 123.19, 125.34 (2C), 127.33, 129.60, 130.03 (2C), 131.93, 134.73 (JCF = 2.55 Hz), 
137.65, 148.29, 149.31, 149.58, 155.36, 158.27 (JCF = 238.8 Hz), 166.31, 167.63; Anal. Calcd. 
For C25H19FN2O5 × 0.5H2O (455.44 g/mol): C, 65.93; H, 4.43; N, 6.15; Found: C, 66.10; H, 
4.40; N, 6.18. 
 
1.5.28. 2-(4-(2-((2-Chlorophenyl)amino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic 
acid × 0.5H2O (5h): Light orange powder; yield: 0.264g (57%); mp 226-227 ºC; IR (KBr, cm
-1): 
3455, 3361, 1700, 1595, 1540, 1518, 1271, 1032, 750; 1H NMR (200 MHz, DMSO-d6): 4.00 (s, 
3H, CH3), 4.90 (s, 2H, CH2), 7.17-7.26 (m, 2H, Ar-H), 7.39 (td, 1H, Ar-H, J = 7.7 Hz and J = 1.4 
Hz), 7.56 (dd, 1H, Ar-H, J = 7.9 Hz and J = 1.5 Hz), 7.64-7.72 (m, 1H, Ar-H), 7.80-7.92 (m, 2H, 
Ar-H), 7.99 (d, 1H, Ar-H, J = 2 Hz), 8.08 (dd, 1H, Ar-H, J = 8.1 Hz and J = 1.5 Hz ), 8.16 (d, 
1H, Ar-H, J = 7.8 Hz) 8.48 (s, 1H, Ar-H), 8.61 (dd, 1H, Ar-H, J = 8.4 Hz and J = 0.8 Hz), 9.63 
(s, 1H, NH), 14.00 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 56.02, 68.11, 110.87, 
114.27, 118.87, 120.24, 123.27, 123.46, 124.50, 125.41, 125.94, 127.40, 127.79, 129.47, 129.66, 
130.08, 132.17, 134.11, 137.74, 148.33, 148.64, 149.48, 155.33, 166.59, 167.73; Anal. Calcd. 
For C25H19ClN2O5 × 0.5H2O (471.89 g/mol): C, 63.63; H, 4.27; N, 5.94; Found: C, 63.39; H, 





acid × 0.5H2O (5i): Light brown powder; yield: 0.148g (32%); mp 248-249 ºC; IR (KBr, cm
-1): 
3391, 1699, 1594, 1519, 1422, 1252, 774; 1H NMR (200 MHz, DMSO-d6): 3.99 (s, 3H, CH3), 
4.85 (s, 2H, CH2), 7.11-7.18 (m, 2H, Ar-H), 7.38 (t, 1H, Ar-H, J = 8 Hz), 7.55 (d, 1H, Ar-H, J = 
8.2 Hz), 7.68 (t, 1H, Ar-H, J = 7.4 Hz), 7.81-7.88 (m, 3H, Ar-H), 7.98 (d, 1H, Ar-H, J = 1.4 Hz), 
8.16 (d, 1H, Ar-H, J = 8.2 Hz), 8.47 (s, 1H, Ar-H), 8.62 (d, 1H, Ar-H, J = 8.2 Hz), 10.41 (s, 1H, 
NH), 14.06 (bs, 1H, COOH). 13C NMR (50 MHz, DMSO-d6): 55.99, 68.45, 111.10, 114.39, 
118.00, 118.82, 119.13, 120.26, 123.22, 123.42, 125.37, 127.34, 129.62, 130.04, 130.43, 131.97, 
133.14, 137.71, 139.84, 148.31, 149.27, 149.58, 155.37, 166.82, 167.67; Anal. Calcd. For 




acid × 0.5H2O (5j): Beige powder; yield: 0.167g (36%); mp 229-230 ºC; IR (KBr, cm
-1): 3300, 
3065, 1707, 1668, 1595, 1539, 1211, 802; 1H NMR (200 MHz, DMSO-d6): 3.99 (s, 3H, CH3), 
4.83 (s, 2H, CH2), 7.14 (d, 1H, Ar-H, J = 8.4 Hz), 7.39-7.45 (m, 2H, Ar-H), 7.64-7.73 (m, 3H, 
Ar-H), 7.80-7.90 (m, 2H, Ar-H), 7.98 (d, 1H, Ar-H, J = 1.8 Hz), 8.16 (d, 1H, Ar-H, J = 7.8 Hz), 
8.47 (s, 1H, Ar-H), 8.60 (dd, 1H, Ar-H, J = 8.4 Hz and J = 0.8 Hz), 10.35 (s, 1H, NH), 13.96 (bs, 
1H, COOH); 13C NMR (50 MHz, DMSO-d6): 55.98, 68.47, 111.03, 114.31, 118.90, 120.28, 
121.19 (2C), 123.25, 125.40, 127.39 (2C), 128.71 (2C), 129.65, 130.09, 131.93, 137.38, 137.63, 
148.34, 149.31, 149.57, 155.40, 166.60, 167.70; Anal. Calcd. For C25H19ClN2O5 × 0.5H2O 
(471.89 g/mol): C, 63.63; H, 4.27; N, 5.94; Found: C, 63.68; H, 4.30; N, 5.96. 
 
1.5.31. 2-(3-Methoxy-4-(2-oxo-2-((2-(trifluoromethyl)phenyl)amino)ethoxy)phenyl)quinoline-4-
carboxylic acid × 0.5H2O (5k): Yellow powder; yield: 0.149g (30%); mp 227-228 ºC; IR (KBr, 
cm-1): 3465, 3405, 2917, 1693, 1594, 1517, 1293, 1178, 1035, 757; 1H NMR (200 MHz, DMSO-
d6): 3.98 (s, 3H, CH3), 4.87 (s, 2H, CH2), 7.17 (d, 1H, Ar-H, J = 8.6 Hz), 7.45 (t, 1H, Ar-H, J = 
7.6 Hz), 7.63-7.68 (m, 1H, Ar-H), 7.71-7.84 (m, 3H, Ar-H), 7.87-7.91 (m, 2H, Ar-H), 7.98 (d, 
1H, Ar-H, J = 1.8 Hz), 8.15 (d, 1H, Ar-H, J = 7.8 Hz), 8.47 (s, 1H, Ar-H), 8.60 (dd, 1H, Ar-H, J 
= 8.2 Hz and J = 0.8 Hz), 9.60 (s, 1H, NH), 13.99 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-
d6): 55.95, 67.91, 110.82, 114.13, 118.91, 120.192, 122.83 (JCF = 29.02 Hz), 123.28, 124.61 (JCF 
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= 271.25 Hz), 125.42, 126.11(C-F), 126.38 (JCF = 3.2 Hz), 127.09 (C-F), 127.43, 129.69, 130.11, 
132.12, 133.28 (C-F), 134.65 (JCF = 1.7 Hz), 137.70, 148.35, 148.68, 149.49, 155.36, 167.15, 
167.75; Anal. Calcd. For C26H19F3N2O5 × 0.5H2O (505.45 g/mol): C, 61.78; H, 3.99; N, 5.54; 
Found: C, 61.68; H, 3.98; N, 5.57. 
 
1.5.32. 2-(3-Methoxy-4-(2-oxo-2-((3-(trifluoromethyl)phenyl)amino)ethoxy)phenyl)quinoline-4-
carboxylic acid × 0.5H2O (5l): Yellow powder; yield: 0.208g (42%); mp ˃ 250 ºC; IR (KBr, cm
-
1): 3379, 2939, 2624, 1702, 1549, 1335, 1251, 1117, 799; 1H NMR (200 MHz, DMSO-d6): 3.98 
(s, 3H, CH3), 4.85 (s, 2H, CH2), 7.13 (d, 1H, Ar-H, J = 8.4 Hz), 7.42-7.46 (m, 1H, Ar-H), 7.55-
7.71 (m, 2H, Ar-H), 7.79-7.88 (m, 3H, Ar-H), 7.96 (d, 1H, Ar-H, J = 1.8 Hz), 8.12-8.16 (m, 2H, 
Ar-H), 8.45 (s, 1H, Ar-H), 8.60 (d, 1H, Ar-H, J = 8.2 Hz), 10.55 (s, 1H, Ar-H), 14.00 (bs, 1H, 
COOH); 13C NMR (50 MHz, DMSO-d6): 55.85, 68.41, 111.10, 114.40, 115.71 (JCF = 3.40 Hz), 
118.78, 119.97 (JCF = 3.25 Hz), 120.25, 123.19 (2C, C-F), 124.05 (JCF = 270.05 Hz), 125.34, 
127.33, 129.55 (JCF = 31.32 Hz), 129.60, 129.99 (2C, C-F),131.97, 137.71, 139.17 (C-F), 148.29, 
149.26, 149.58, 155.35, 167.04, 167.64; Anal. Calcd. For C26H19F3N2O5 × 0.5H2O (505.45 
g/mol): C, 61.78; H, 3.99; N, 5.54; Found: C, 61.54; H, 3.95; N, 5.50. 
 
1.5.33. 2-(3-Methoxy-4-(2-oxo-2-((4-(trifluoromethyl)phenyl)amino)ethoxy)phenyl)quinoline-4-
carboxylic acid × 1.5H2O (5m): Beige powder; yield: 0.169g (34%); mp 211-212 ºC; IR (KBr, 
cm-1): 3393, 2499, 1701, 1603, 1543, 1523, 1331, 1272, 1113, 841; 1H NMR (200 MHz, DMSO-
d6): 3.98 (s, 3H, CH3), 4.86 (s, 2H, CH2), 7.12 (d, 1H, Ar-H, J = 8.4 Hz), 7.63-7.73(m, 3H, Ar-
H), 7.79-7.89 (m, 4H, Ar-H), 7.96 (d, 1H, Ar-H, J = 2 Hz), 8.14 (dd, 1H, Ar-H, J = 8.4 Hz and J 
= 0.6 Hz), 8.44 (s, 1H, Ar-H), 8.60 (dd, 1H, Ar-H, J = 8.5 Hz and J = 0.9 Hz), 10.56 (s, 1H, NH), 
13.79 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 56.00, 68.47, 111.13, 114.41, 118.86, 
119.54 (2C, C-F), 120.28, 123.25, 123.84 (JCF = 31.72 Hz), 124.35 (JCF = 269.65 Hz), 125.40 
(2C), 126.08 (JCF = 3.32 Hz), 127.36, 129.64, 130.06, 132.02, 137.71, 142.00 (C-F), 148.34, 
149.28, 149.60, 155.39, 167.10, 167.70; Anal. Calcd. For C26H19F3N2O5 × 1.5H2O (523.47 
g/mol): C, 59.66; H, 4.24; N, 5.35; Found: C, 59.97; H, 4.27; N, 5.36. 
 
1.5.34. 2-(4-(2-(Benzylamino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic acid (5n): 
Beige powder; yield: 0.150g (34%); mp 199-200 ºC; IR (KBr, cm-1): 3390, 2923, 1703, 1636, 
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1518, 1422, 1245, 1214, 1031, 809; 1H NMR (200 MHz, DMSO-d6): 3.95 (s, 3H, CH3), 4.38 (d, 
2H, -NHCH2, J = 6.0 Hz), 4.69 (s, 2H, CH2), 7.42 (d, 1H, Ar-H, J = 8.6 Hz), 7.24-7.35 (m, 5H, 
Ar-H), 7.64-7.73 (m, 1H, Ar-H), 7.81-7.88 (m, 2H, Ar-H), 7.96 (d, 1H, Ar-H, J = 2 Hz), 8.16 
(dd, 1H, Ar-H, J = 8.3 Hz and  J = 0.5 Hz), 8.47 (s, 1H, Ar-H), 8.58 (t, 1H, NH, J = 6.0 Hz), 8.62 
(dd, 1H, Ar-H, J = 8.5 Hz and J = 0.9 Hz) 13.98 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-
d6): 42.13, 55.96, 68.54, 111.04, 114.64, 118.87, 120.25, 123.23, 125.38, 126.87 (2C), 127.34 
(2C), 127.42, 128.30 (2C), 129.66, 130.12, 132.01, 137.69, 139.16, 148.34, 149.29, 149.65, 
155.42, 167.70; Anal. Calcd. For C26H22N2O5 (442.46 g/mol): C, 70.58; H, 5.01; N, 6.33; Found: 
C, 70.37; H, 5.00; N, 6.29. 
 
1.5.35. 2-(3-Methoxy-4-(2-oxo-2-((pyridin-3-ylmethyl)amino)ethoxy)phenyl)quinoline-4-
carboxylic acid × 1H2O (5o): Light brown powder; yield: 0.226g (51%); mp 215-216 ºC; IR 
(KBr, cm-1): 3357, 2930, 1680, 1588, 1516, 1424, 1250, 1172, 1029, 797; 1H NMR (200 MHz, 
DMSO-d6): 3.95 (s, 3H, CH3), 4.41 (d, 2H, NHCH2, J = 5.8 Hz), 4.69 (s, 2H, CH2), 7.10 (d, 1H, 
Ar-H, J = 8.4 Hz), 7.34-7.40 (m, 1H, Py-H), 7.65-7.72 (m, 2H, Ar-H, Py-H), 7.81-7.88 (m, 2H, 
Ar-H), 7.96 (d, 1H, Ar-H, J = 1.4 Hz), 8.16 (d, 1H, Ar-H, J = 8 Hz), 8.46 (s, 1H, Ar-H), 8.53-
8.71 (m, 4H, NH, Ar-H, 2 Py-H); 13C NMR (50 MHz, DMSO-d6): 39.88, 55.96, 68.52, 111.06, 
114.63, 118.83, 120.23, 123.24 (2C), 125.40, 127.40, 129.65, 130.11, 132.06, 135.25 (2C), 
137.83, 148.04, 148.33, 148.76, 149.23, 149.65, 155.40, 167.73, 167.98; Anal. Calcd. For 




carboxylic acid × 1H2O (5p): Beige powder; yield: 0.238g (55%); mp 229-230 ºC; IR (KBr, cm
-
1): 3444, 2936, 1705, 1630, 1590, 1517, 1427, 1256, 1150, 780; 1H NMR (200 MHz, DMSO-d6): 
3.94 (s, 3H, CH3), 4.36 (d, 2H, NHCH2, J = 5.8 Hz), 4.64 (s, 2H, CH2), 6.26 (d, 1H, Fur-H, J = 
2.8 Hz), 6.40 (dd, 1H, Fur-H, J = 3.1 Hz and J = 1.9 Hz), 7.08 (d, 1H, Ar-H, J = 8.4 Hz), 7.59-
7.71 (m, 2H, Ar-H, Fur-H), 7.81-7.87 (m, 2H, Ar-H), 7.94 (d, 1H, Ar-H, J = 1.8 Hz), 8.14 (d, 1H, 
Ar-H, J = 8 Hz), 8.44 (s, 1H, Ar-H), 8.49 (t, 1H, NH, J = 5.8 Hz), 8.59 (d, 1H, Ar-H, J = 8 Hz), 
13.87 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 35.49, 55.95, 68.36, 106.95, 110.48, 
110.99, 114.56, 118.81, 120.22, 123.18, 125.34, 127.38, 129.62, 130.09, 131.95, 137.69, 142.09, 
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148.29, 149.25, 149.59, 151.94, 155.38, 167.53, 167.65; Anal. Calcd. For C24H20N2O6 × 1H2O 
(450.45 g/mol): C, 64.47; H, 4.81; N, 6.18; Found: C, 63.99; H, 4.92; N, 6.22. 
 
1.5.37. 2-(3-Methoxy-4-(2-oxo-2-((thiophen-2-ylmethyl)amino)ethoxy)phenyl)quinoline-4-
carboxylic acid × 0.5H2O (5q): Brown powder; yield: 0.233 (52%); mp 206-207 ºC; IR (KBr, 
cm-1): 3346, 2935, 1700, 1632, 1587, 1516, 1255, 1212, 1146, 696; 1H NMR (200 MHz, DMSO-
d6): 3.95 (s, 3H, CH3), 4.54 (d, 2H, NHCH2, J = 5.8 Hz), 4.65 (s, 2H, CH2), 6.95-7.02 (m, 2H, 
Thio-H), 7.08 (d, 1H, Ar-H, J = 8.6 Hz), 7.41 (dd, 1H, Thio-H, J = 4.9 Hz and J = 1.5 Hz), 7.64-
7.72 (m, 1H, Ar-H), 7.82-7.87 (m, 2H, Ar-H), 7.95 (d, 1H, Ar-H, J = 2 Hz), 8.15 (d, 1H, Ar-H, J 
= 7.8 Hz), 8.46 (s, 1H, Ar-H), 8.61 (dd, 1H, Ar-H, J = 8.4 Hz and J = 0.8 Hz), 8.67 (t, 1H, NH, J 
= 5.8 Hz), 14.00 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 37.17, 55.91, 68.38, 110.98, 
114.55, 118.82, 120.19, 123.21, 125.06, 125.37, 125.60, 126.65, 127.36, 129.62, 130.05, 131.97, 
137.70, 141.98, 148.30, 149.23, 149.59, 155.36, 167.51, 167.68; Anal. Calcd. For C24H20N2O5S 
× 0.5H2O (457.50 g/mol): C, 63.01; H, 4.63; N, 6.12; S, 7.01; Found: C, 63.31; H, 4.61; N, 6.11; 
S, 7.13. 
 
1.5.38. 2-(4-(2-(Hexylamino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic acid (5r): 
White powder; yield: 0.157g (36%); mp 179-180 ºC; IR (KBr, cm-1): 3422, 2931, 1712, 1647, 
1549, 1519, 1247, 1036, 798; 1H NMR (200 MHz, DMSO-d6): 0.84 (t, 3H, CH3, J = 6.3 Hz), 
1.23-1.46 (m, 8H, CH2), 3.14 (q, 2H, -NH-CH2-CH2-, J = 6.5 Hz), 3.97 (s, 3H, OCH3), 4.58 (s, 
2H, -OCH2-CO-), 7.08 (d, 1H, Ar-H, J = 8.6 Hz), 7.67-7.72 (m, 1H, Ar-H), 7.83-7.88 (m, 2H, 
Ar-H), 7.96 (d, 1H, Ar-H, J = 1.8 Hz), 7.99 (t, 1H, NH, J = 6.0 Hz), 8.15 (d, 1H, Ar-H, J = 7.8 
Hz), 8.46 (s, 1H, Ar-H), 8.61 (d, 1H, Ar-H, J = 7.8 Hz), 14.01 (bs, 1H, COOH); 13C NMR (50 
MHz, DMSO-d6): 13.92, 22.13, 26.10, 29.10, 31.06, 38.45, 55.93, 68.50, 110.95, 114.44, 118.82, 
120.20, 123.22, 125.36, 127.33, 129.61, 130.02, 131.90, 137.59, 148.32, 149.27, 149.58, 155.35, 
167.31, 167.65; Anal. Calcd. For C25H28N2O5 (436.50 g/mol): C, 68.79; H, 6.47; N, 6.42; Found: 
C, 69.08; H, 6.46; N, 6.51. 
 
1.5.39. 2-(4-(2-(Cyclohexylamino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-carboxylic acid 
(5s): Yellow powder; yield: 0.252g (58%); mp 230-231 ºC; IR (KBr, cm-1): 3443, 3267, 2934, 
1704, 1655, 1518, 1252, 774; 1H NMR (200 MHz, DMSO-d6): 1.19-1.76 (m, 10H, cyclohexyl), 
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3.59 (m, 1H, cyclohexyl), 3.96 (s, 3H, CH3), 4.56 (s, 2H, -OCH2-), 7.07 (d, 1H, Ar-H, J = 8.6 
Hz), 7.62-7.70 (m, 1H, Ar-H), 7.78-7.86 (m, 3H, Ar-H), 7.94 (d, 1H, NH, J = 1.8 Hz), 8.14 (d, 
1H, Ar-H, J = 8 Hz), 8.44 (s, 1H, Ar-H), 8.59 (d, 1H, Ar-H, J = 8 Hz), 13.09 (bs, 1H, COOH); 
13C NMR (50 MHz, DMSO-d6): 24.59 (2C), 25.28, 32.37 (2C), 47.47, 55.95, 68.51, 110.87, 
114.51, 118.81, 120.26, 123.23, 125.41, 127.38, 129.64, 130.10, 131.86, 137.85, 148.31, 149.35, 
149.55, 155.38, 166.46, 167.75; Anal. Calcd. For C25H26N2O5 (434.48 g/mol): C, 69.11; H, 6.03; 
N, 6.45; Found: C, 72.42; H, 6.25; N, 6.67. 
 
1.5.40. 2-(4-(2-((1s,3s)-Adamantan-1-ylamino)-2-oxoethoxy)-3-methoxyphenyl)quinoline-4-
carboxylic acid × 1H2O (5t): White powder; yield: 0.180g (37%); mp 226-227 ºC; IR (KBr, cm
-
1): 3443, 3389, 2908, 1625, 1549, 1515, 1255, 1143, 778; 1H NMR (200 MHz, DMSO-d6): 1.63 
(s, 6H, Ad), 1.97-2.02 (m, 9H, Ad), 3.96 (s, 3H, CH3), 4.51 (s, 2H, CH2), 7.09 (d, 1H, Ar-H, J = 
8.6 Hz), 7.35 (s, 1H, NH), 7.63-7.71(m, 1H, Ar-H), 7.79-7.88 (m, 2H, Ar-H), 7.94 (d, 1H, Ar-H, 
J = 1.8 Hz), 8.14 (d, 1H, Ar-H, J = 8 Hz), 8.45 (s, 1H, Ar-H), 8.59 (dd, 1H, Ar-H, J = 8.4 Hz and 
J =1 Hz), 13.98 (bs, 1H, COOH); 13C NMR (50 MHz, DMSO-d6): 28.98 (3C), 36.06 (3C), 41.13 
(3C), 51.06, 56.00, 68.50, 110.87, 114.44, 118.86, 120.31, 123.25, 125.41, 127.39, 129.65, 
130.10, 131.82, 137.73, 148.34, 149.28, 149.47, 155.39, 166.47, 167.73; Anal. Calcd. For 


















Fig. S1. The bioactive conformation of 5k as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S2. The bioactive conformation of 5i as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S3. The bioactive conformation of 5l as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S4. The bioactive conformation of 5e as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S5. The bioactive conformation of 5o as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S6. The bioactive conformation of 5p as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S7. The bioactive conformation of 5h as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S8. The bioactive conformation of 5g as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S9. The bioactive conformation of 5s as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S10. The bioactive conformation of 5t as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S11. The bioactive conformation of 5c as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S12. The bioactive conformation of 5f as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S13. The bioactive conformation of 5m as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S14. The bioactive conformation of 5r as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S15. The bioactive conformation of 5q as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S16. The bioactive conformation of 5n as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S17. The bioactive conformation of 5d as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 




Fig. S18. The bioactive conformation of 5a as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 






Fig. S19. The bioactive conformation of 5b as hDHODH inhibitor. For the clarity of presentation, the 
hydrogens were omitted, the N-terminal amino acids, orotate as hDHODH substrate, and FMN as 
hDHODH coenzyme were depicted, whereas the remaining of the enzyme is illustrated with the surface. 
The established hydrogen bonds are presented with black lines. 
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 Copies of 1H and 13C NMR spectra for 4a-4t 
 

































































Figure S36. 1H NMR spectrum of 4i in DMSO-d6 (200 MHz). 
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Figure S59. 13C NMR spectrum of 4t in DMSO-d6 (50 MHz). 
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Copies of 1H and 13C NMR spectra for 5a-5t 
 
  












Figure S63. 13C NMR spectrum of 5b in DMSO-d6 (50 MHz).  
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Figure S80. 1H NMR spectrum of 5k in DMSO-d6 (200 MHz).    
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Figure S89. 13C NMR spectrum of 5o in DMSO-d6 (50 MHz).   
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Figure S99. 13C NMR spectrum of 5t in DMSO-d6 (50 MHz).   
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Copies of IR spectra for 4a-4t 
 
 
Figure S100. IR spectrum of 4a.   


















































































































Figure S101. IR spectrum of 4b. 



































































































Figure S102. IR spectrum of 4c.  































































































Figure S103. IR spectrum of 4d.   

































































































Figure S104. IR spectrum of 4e.    






































































































   
Figure S105. IR spectrum of 4f.    





















































































































Figure S106. IR spectrum of 4g.     
































































































Figure S107. IR spectrum of 4h.      















































































































Figure S108. IR spectrum of 4i.   





































































































Figure S109. IR spectrum of 4j.   
  































































































Figure S110. IR spectrum of 4k.   






























































































Figure S111. IR spectrum of 4l.    













































































































Figure S112. IR spectrum of 4m.     












































































































Figure S113. IR spectrum of 4n.  




































































































Figure S114. IR spectrum of 4o.   













































































































Figure S115. IR spectrum of 4p.    
























































































Figure S116. IR spectrum of 4q.    



































































































Figure S117. IR spectrum of 4r.     
















































































   
Figure S118. IR spectrum of 4s.  

























































































    
Figure S119. IR spectrum of 4t.  








































































































Copies of IR spectra for 5a-5t  
 
Figure S120. IR spectrum of 5a.   














































































































Figure S121. IR spectrum of 5b.   

















































































Figure S122. IR spectrum of 5c.   


























































































Figure S123. IR spectrum of 5d.    






































































































Figure S124. IR spectrum of 5e.    
























































































Figure S125. IR spectrum of 5f.    

































































































Figure S126. IR spectrum of 5g.  









































































































Figure S127. IR spectrum of 5h.   



























































































   
Figure S128. IR spectrum of 5i.    




























































































Figure S129. IR spectrum of 5j.    


































































































Figure S130. IR spectrum of 5k.     





























































































Figure S131. IR spectrum of 5l.     
























































































Figure S132. IR spectrum of 5m.     





















































































Figure S133. IR spectrum of 5n.     
























































































Figure S134. IR spectrum of 5o.      







































































































Figure S135. IR spectrum of 5p.       





















































































Figure S136. IR spectrum of 5q.         

































































































Figure S137. IR spectrum of 5r. 


























































































Figure S138. IR spectrum of 5s.  

























































































Figure S139. IR spectrum of 5t.












































































3. Inhibition of hDHODH and cytotoxicity 
 
The inhibiton of human dihydroorotate dehydrogenase (hDHODH) activity by 
synthesized compounds (5a-5t) as well as cytotoxicity against HaCat cell line were determined 
according to previosly reported procedure [1].  
 
4. Docking studies  
 




[1] Petrović MM, Roschger C, Chaudary S, Zierer A, Mladenović M, Jakovljević K, Marković V, Botta 
B, Joksović M D. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-
carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular 
docking studies. Bioorg. Chem. 2020;105;104373. https://doi.org/10.1016/j.bioorg.2020.104373. 
